Sudarshan Pharma Industries Ltd

Sudarshan Pharma Industries Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 Oct 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Sudarshan Pharma Industries, a key player in the Specialty Chemicals sector, has exhibited a notable shift in its technical momentum as of late December 2025. The stock’s recent price movements and technical indicators suggest a transition from a bearish stance to a more nuanced mildly bearish outlook, reflecting evolving market dynamics and investor sentiment.

Sudarshan Pharma, a microcap player in the Specialty Chemicals sector, has undergone a revision in its market evaluation metrics, reflecting a nuanced view of its recent financial and technical performance. This shift comes amid a backdrop of mixed signals across key analytical parameters, including quality, valuation, financial trends, and technical outlook.

Sudarshan Pharma Industries, a key player in the specialty chemicals sector, has experienced a notable shift in its technical momentum and market assessment. Recent data reveals changes in key technical indicators including MACD, RSI, moving averages, and Bollinger Bands, reflecting evolving investor sentiment and price dynamics amid broader market conditions.

Sudarshan Pharma Industries, a key player in the Specialty Chemicals sector, has experienced a notable shift in its technical momentum, reflecting changes in market sentiment and price dynamics. Recent evaluation adjustments reveal a transition from a bearish to a mildly bearish technical trend, accompanied by mixed signals from key indicators such as MACD, RSI, and moving averages. This article analyses these developments in the context of the company’s price performance and broader market conditions.

Sudarshan Pharma Industries has experienced a notable shift in its technical momentum, reflecting evolving market dynamics within the specialty chemicals sector. Recent evaluation adjustments reveal a transition from mildly bearish to bearish technical trends, underscoring a complex interplay of price movements and indicator signals that investors should carefully consider.

Sudarshan Pharma Industries, a key player in the Specialty Chemicals sector, has experienced a notable shift in its technical momentum as recent market data reveals changes in key indicators such as MACD, RSI, and moving averages. The stock’s price movement and technical signals suggest a nuanced market assessment amid broader sector and benchmark trends.

Sudarshan Pharma Industries has witnessed extraordinary buying momentum today, with the stock hitting the upper circuit and registering only buy orders in the queue. This rare market phenomenon signals intense demand and the possibility of a sustained multi-day circuit scenario, setting the stage for close investor attention in the specialty chemicals sector.

Sudarshan Pharma, a microcap player in the Specialty Chemicals sector, has undergone a revision in its market evaluation metrics, reflecting a nuanced view of its recent financial and technical performance. The stock’s assessment now incorporates a blend of stable financial trends, attractive valuation, average quality indicators, and bearish technical signals, providing investors with a comprehensive perspective on its current standing.

Sudarshan Pharma Industries has encountered significant selling pressure in the latest trading session, with the stock registering a sharp decline and exhibiting a complete absence of buyers. This distress selling signals heightened investor caution as the stock breaks a four-day streak of gains and trades well below key moving averages.

Sudarshan Pharma Industries has experienced significant selling pressure, with the stock registering a sharp decline of 4.96% today and showing no buying interest. The persistent downward trend over multiple time frames highlights distress selling signals, as the stock trades close to its 52-week low and remains below all key moving averages.

Sudarshan Pharma Industries Ltd is experiencing significant selling pressure, with the stock declining over the past three days. It has underperformed compared to the Sensex across various time frames, including a year-to-date drop of 45.91%. The stock is trading below multiple moving averages, indicating a downward trend.

Sudarshan Pharma Industries Ltd is experiencing notable selling pressure, with consecutive losses over recent days. The stock has declined significantly over the past week and month, contrasting sharply with the Sensex's modest decline. Yearly performance shows a substantial drop, indicating ongoing challenges in the specialty chemicals sector.

Sudarshan Pharma Industries Ltd is experiencing notable selling pressure, with its stock declining after six days of gains. Despite a recent positive week, its longer-term performance shows significant losses, including a year-to-date drop of nearly 39%. The stock remains below key moving averages, indicating market challenges.